Robert A. Bonomo

Molecular Medicine · 2000–2021

A researcher in the Science corpus: 15 papers; trusts 8 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

• Molecular Medicine — 83 citations into it; #201 of 296 by trust here, #35 by citations
• Endocrinology — 34 citations into it
• Molecular Biology — 23 citations into it; #13,545 of 17,773 by trust here, #12,742 by citations
• Pharmacology — 23 citations into it
• Applied Microbiology and Biotechnology — 20 citations into it
• Infectious Diseases — 14 citations into it
• Pollution — 10 citations into it; #1,341 of 1,888 by trust here, #1,271 by citations

Whom Robert A. Bonomo trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. P. Nordmann
2. L. Poirel
3. T. Walsh
4. G. Jacoby
5. K. Bush
6. L. Rice
7. K. Poole

Who trusts Robert A. Bonomo overall

1. G. Meletis
2. L. Maragakis
3. Jasmine Lee
4. P. Tamma
5. C. Giske
6. A. Potron

Papers from Robert A. Bonomo's perspective

Ordered by how strongly the researchers Robert A. Bonomo trusts endorse each paper. Same corpus, a different order for every researcher.

1. Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes (Antimicrobial Agents and Chemotherapy)
2. Metallo-β-Lactamases: the Quiet before the Storm? (Clinical Microbiology Reviews)
3. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. (Clinical Microbiology and Infection)
4. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. (Lancet. Infectious Diseases (Print))
5. Efflux-mediated multiresistance in Gram-negative bacteria. (Clinical Microbiology and Infection)
6. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. (Clinical Microbiology and Infection)
7. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. (Chest)
8. Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India (Antimicrobial Agents and Chemotherapy)
9. The epidemiology and control of Acinetobacter baumannii in health care facilities. (Clinical Infectious Diseases)
10. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. (Journal of Infectious Diseases)

Their papers

• Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. (2006) — 772 citations
• European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (endorsed by ESICM -European Society of intensive care Medicine). (2021) — 838 citations
• Infectious Diseases Society of America Antimicrobial Resistant Treatment Guidance: Gram-Negative Bacterial Infections. (2020) — 636 citations
• Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges (2016) — 956 citations
• 10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. (2013) — 613 citations
• Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases (2013) — 1,554 citations
• Better Tests, Better Care: Improved Diagnostics for Infectious Diseases (2013) — 615 citations
• Carbapenems: Past, Present, and Future (2011) — 1,298 citations
• Three Decades of β-Lactamase Inhibitors (2010) — 1,340 citations
• The role of a second-shell residue in modifying substrate and inhibitor interactions in the SHV beta-lactamase: a study of ambler position Asn276. (2009) — 33 citations
• Global Challenge of Multidrug-Resistant Acinetobacter baumannii (2007) — 1,265 citations
• International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum -Lactamase Production in Nosocomial Infections (2004) — 673 citations
• Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. (2004) — 604 citations
• Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory (2001) — 600 citations
• Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. (2000) — 690 citations